Conti RM - Search Results

1

Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.

Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Qato DM, et al. Among authors: conti rm. JAMA. 2008 Dec 24;300(24):2867-78. doi: 10.1001/jama.2008.892. JAMA. 2008. PMID: 19109115 Free PMC article.

2

Racial and ethnic disparities in cardiovascular medication use among older adults in the United States.

Qato DM, Lindau ST, Conti RM, Schumm LP, Alexander GC. Qato DM, et al. Among authors: conti rm. Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):834-42. doi: 10.1002/pds.1974. Pharmacoepidemiol Drug Saf. 2010. PMID: 20681002 Free PMC article.

3

Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009.

Pillarella J, Higashi A, Alexander GC, Conti R. Pillarella J, et al. Psychiatr Serv. 2012 Jan;63(1):83-6. doi: 10.1176/appi.ps.201100092. Psychiatr Serv. 2012. PMID: 22227765 Free PMC article.

4

Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010.

Garfield CF, Dorsey ER, Zhu S, Huskamp HA, Conti R, Dusetzina SB, Higashi A, Perrin JM, Kornfield R, Alexander GC. Garfield CF, et al. Acad Pediatr. 2012 Mar-Apr;12(2):110-6. doi: 10.1016/j.acap.2012.01.003. Epub 2012 Feb 10. Acad Pediatr. 2012. PMID: 22326727 Free PMC article.

5

Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.

Kornfield R, Watson S, Higashi AS, Conti RM, Dusetzina SB, Garfield CF, Dorsey ER, Huskamp HA, Alexander GC. Kornfield R, et al. Among authors: conti rm. Psychiatr Serv. 2013 Apr 1;64(4):339-46. doi: 10.1176/appi.ps.201200147. Psychiatr Serv. 2013. PMID: 23318985 Free PMC article.

6

Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.

Dusetzina SB, Higashi AS, Dorsey ER, Conti R, Huskamp HA, Zhu S, Garfield CF, Alexander GC. Dusetzina SB, et al. Med Care. 2012 Jun;50(6):466-78. doi: 10.1097/MLR.0b013e318245a160. Med Care. 2012. PMID: 22266704 Free PMC article. Review.

7

Impact of FDA black box advisory on antipsychotic medication use.

Dorsey ER, Rabbani A, Gallagher SA, Conti RM, Alexander GC. Dorsey ER, et al. Among authors: conti rm. Arch Intern Med. 2010 Jan 11;170(1):96-103. doi: 10.1001/archinternmed.2009.456. Arch Intern Med. 2010. PMID: 20065205 Free PMC article.

8

Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory.

Dusetzina SB, Busch AB, Conti RM, Donohue JM, Alexander GC, Huskamp HA. Dusetzina SB, et al. Among authors: conti rm. Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1251-60. doi: 10.1002/pds.3272. Epub 2012 May 3. Pharmacoepidemiol Drug Saf. 2012. PMID: 22553074 Free PMC article.

9

How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab.

Dusetzina SB, Ellis S, Freedman RA, Conti RM, Winn AN, Chambers JD, Alexander GC, Huskamp HA, Keating NL. Dusetzina SB, et al. Among authors: conti rm. J Oncol Pract. 2015 Jul;11(4):313-8. doi: 10.1200/JOP.2015.004218. Epub 2015 Jun 9. J Oncol Pract. 2015. PMID: 26060224 Free PMC article.

10

Cost consequences of the 340B drug discount program.

Conti RM, Bach PB. Conti RM, et al. JAMA. 2013 May 15;309(19):1995-6. doi: 10.1001/jama.2013.4156. JAMA. 2013. PMID: 23609758 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page